000 01303 a2200373 4500
005 20250513131343.0
264 0 _c19971212
008 199712s 0 0 eng d
022 _a0031-6865
024 7 _a10.1016/s0031-6865(97)00016-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQueiroz, R H
245 0 0 _aHaematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
_h[electronic resource]
260 _bPharmaceutica acta Helvetiae
_cSep 1997
300 _a209-13 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aClofazimine
_xadministration & dosage
650 0 4 _aDapsone
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeprostatic Agents
_xadverse effects
650 0 4 _aLeprosy
_xblood
650 0 4 _aMale
650 0 4 _aMethemoglobinemia
_xchemically induced
650 0 4 _aRifampin
_xadministration & dosage
700 1 _aMelchior JĂșnior, E
700 1 _ade Souza, A M
700 1 _aGouveia, E
700 1 _aBarbosa, J C
700 1 _ade Carvalho, D
773 0 _tPharmaceutica acta Helvetiae
_gvol. 72
_gno. 4
_gp. 209-13
856 4 0 _uhttps://doi.org/10.1016/s0031-6865(97)00016-2
_zAvailable from publisher's website
999 _c9342528
_d9342528